Coronado Biosciences slides on possible Summer Street bear call

Coronado Biosciences (CNDO -4.5%) is trading notably lower on the session.

The move may be attributable to a bearish note out of Summer Street.

Just a guess: There may be skepticism around the company's lead product candidate TSO which is in Phase 2 testing for Crohn's disease and ulcerative colitis.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs